Table 2 Euglycemic-hyperinsulinemic clamp before and after ω-3PUFA supplementation.

From: ω-3PUFA supplementation ameliorates adipose tissue inflammation and insulin-stimulated glucose disposal in subjects with obesity: a potential role for apolipoprotein E

 

Pre-FO

Post-FO

P value vs. Pre-FO

Endogenous glucose production (EGP) (basal) (mg/kg ffm•min)

2.9 ± 0.1

3.0 ± 0.1

P = 0.524

EGP during insulin infusion

0.0 ± 0.3

0.0 ± 0.1

P = 0.819

(mg/kg ffm•min)

   

Glucose disposal

4.7 ± 0.6

5.9 ± 0.9

P < 0.05

(mg/kg ffm•min)

   

Plasma insulin level (basal)

16.2 ± 4.5

19.9 ± 8.0

P = 0.701

(µIU/ml)

   

Plasma insulin level (90–120 min insulin infusion)

190.2 ± 17.3

203.9 ± 12.0

P = 0.538

(µIU/ml)

   
Back to article page